Study Reveals Mechanisms Cancer Cells Use to Establish Metastatic Brain Tumors

Key points
- New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.
- Journalists may contact the Department of Public Affairs for more information.
- Metastasis, the process that allows some cancer cells to break off from their tumor of origin and take root in a different tissue, is the most common reason people die from cancer.
- Yet most tumor cells die before they can take root in the brain, which is better protected than most organs against colonization by circulating tumor cells.
New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the February 27 issue of Cell, the study found that tumor cells that reach the brain - and successfully grow into new tumors - hug capillaries and express specific proteins that overcome the brain's natural defense against metastatic invasion.
Metastasis, the process that allows some cancer cells to break off from their tumor of origin and take root in a different tissue, is the most common reason people die from cancer. Metastatic brain tumors are ten times more common than primary brain cancers.
Yet most tumor cells die before they can take root in the brain, which is better protected than most organs against colonization by circulating tumor cells. To seed in the brain, a cancer cell must dislodge from its tumor of origin, enter the bloodstream, and cross densely packed blood vessels called the blood-brain barrier. Until now, little research has been done into how metastatic brain tumors develop, but previous mouse experiments that imaged metastatic breast cancer cells over time have shown that of those cancer cells that do make it to the brain, fewer than one in 1,000 survive.
"We didn't know why so many of these cells die," says Joan Massague', PhD, Director of the Sloan Kettering Institute and senior author of the study. "What kills them? And how do occasional cells survive in this vulnerable state - sometimes hiding out in the brain for years - to eventually spawn new tumors? What keeps these rare cells alive and where do they hide?"
In the Cell study, Dr. Massague', with Fellow Manuel Valiente, PhD, and other team members, found that in mouse models of breast and lung cancer - two tumor types that often spread to the brain - many cancer cells that enter the brain are killed by astrocytes. These killer cells, the most common type of brain cell, secrete a protein called Fas ligand.
When cancer cells encounter this protein, they are triggered to self-destruct. The exceptional cancer cells that escape the astrocytes do so by producing a protein called Serpin, which acts as a sort of antidote to the death signals fired at them by nearby astrocytes.
After imaging defiant metastatic cells in the brains of mice, researchers noticed that the cells that were able to survive grew on top of blood capillaries, each cell sticking closely to its vessel "like a panda bear hugging a tree trunk," Dr. Massague' says. They found that the tumor cells produce a protein that acts like Velcro to attach the cells to the outer wall of a blood vessel.
"This hugging is clearly essential," Dr. Massague' explains. "If a tumor cell detaches from its vessel, it gets killed by nearby astrocytes. By staying on, it gets nourished and protected, and may eventually start dividing to form a sheath around the vessel."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsOvarian cancer cells are more aggressive on soft tissues
When ovarian cancer spreads from the ovaries it almost always does so to a layer of fatty tissue that lines the gut. A new study has found that ovarian cancer cells are more aggressive on these soft tissues due to the…
9 May 2014
NewsMeasure of circulating tumor cells may be better predictor of prostate cancer survival than PSA test
New research by USC Norris Comprehensive Cancer Center scientists demonstrates that measuring circulating tumor cells (CTCs) - the cells that spread cancer through the body – may be a better predictor of patient…
23 March 2014
NewsStudy reveals a major mechanism driving kidney cancer progression
The shortage of oxygen, or hypoxia, created when rapidly multiplying kidney cancer cells outgrow their local blood supply can accelerate tumor growth by causing a nuclear protein called SPOP - which normally suppresses…






